You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

17-261

Showing 1 - 25 of 4,533
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced/Metastatic Solid Tumor Trial in United States (KZR-261)

Recruiting
  • Advanced/Metastatic Solid Tumor
  • Los Angeles, California
  • +6 more
Aug 10, 2022

Psoriatic Arthritis Trial in Worldwide (Filgotinib, Placebo to match filgotinib)

Terminated
Has Results
  • Psoriatic Arthritis
  • Covina, California
  • +58 more
Feb 18, 2022

Brain Tumor Trial in United States (abemaciclib)

Active, not recruiting
  • Brain Tumor
  • Hartford, Connecticut
  • +7 more
Mar 30, 2022

Assess Urine Biomarkers to Predict Nephropathy in Fabry Disease

Recruiting
  • Fabry Disease
    • Rockville, Maryland
    • +1 more
    Sep 29, 2023

    Metastatic Colorectal Cancer Trial in Worldwide (Cetuximab, Panitumumab)

    Completed
    Has Results
    • Metastatic Colorectal Cancer
    • Stockton, California
    • +151 more
    Sep 8, 2022

    Immune Thrombocytopenia Trial in Worldwide (SKI-O-703, Placebo oral tablet)

    Unknown status
    • Immune Thrombocytopenia
    • Los Angeles, California
    • +26 more
    Sep 16, 2020

    Epilepsy Trial in Worldwide (USL261)

    Terminated
    Has Results
    • Epilepsy
    • Phoenix, Arizona
    • +57 more
    Jan 19, 2023

    Epilepsy Trial in Worldwide (Placebo, Brivaracetam, Antiepileptic drugs with market authorization available per country)

    Completed
    Has Results
    • Epilepsy
    • Placebo
    • +2 more
    • Phoenix, Arizona
    • +206 more
    Jul 14, 2022

    Motivation to Change Lifestyle Habits in Youth With Obesity

    Completed
    • Pediatric Obesity
    • Motivational Interviewing
      • Calgary, Alberta, Canada
      • +1 more
      May 25, 2022

      Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

      Active, not recruiting
      Has Results
      • Breast Cancer
      • Trastuzumab deruxtecan (T-DXd)
      • Ado-trastuzumab emtansine (T-DM1)
      • Los Angeles, California
      • +163 more
      Apr 1, 2022

      Melanoma, Non-small Sell Lung Cancer (NSCLC), Triple Negative Breast Cancer Trial in Worldwide (PDR001)

      Completed
      Has Results
      • Melanoma
      • +4 more
      • PDR001
      • Baltimore, Maryland
      • +40 more
      Aug 2, 2022

      Metastatic Breast Cancer Trial in Pompano Beach, Caracas (ConvitVax)

      Not yet recruiting
      • Metastatic Breast Cancer
      • ConvitVax
      • Pompano Beach, Florida
      • +2 more
      Aug 28, 2023

      Hemophilia B Trial in Beijing (Sodium valproate extended-release tablets)

      Recruiting
      • Hemophilia B
      • Sodium valproate extended-release tablets
      • Beijing, China
        PLA General Hospital
      Jun 17, 2023

      Hypercholesterolemia Trial (ezetimibe (+) simvastatin, Comparator: atorvastatin, Comparator: rosuvastatin)

      Completed
      Has Results
      • Hypercholesterolemia
      • ezetimibe (+) simvastatin
      • +2 more
      • (no location specified)
      Feb 7, 2022

      Atrial Fibrillation, Catheter Ablation Trial in Napoli

      Recruiting
      • Atrial Fibrillation
      • Catheter Ablation
        • Napoli, Italy
          Clinica Mediterranea
        Mar 8, 2023

        Knee Trial in Barcelona (Bone lavage previous to cementation)

        Active, not recruiting
        • Knee
        • Bone lavage previous to cementation
        • Barcelona, Spain
          Hospital de la Santa Creu i Sant Pau
        Sep 4, 2023

        HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

        Active, not recruiting
        Has Results
        • HIV Infections
        • DTG 50 mg
        • +2 more
        • Bakersfield, California
        • +61 more
        Dec 3, 2021

        COPD Trial in Rahim yar khan (Anterior Chest Compression technique, Abdominal Thrust Technique)

        Not yet recruiting
        • COPD
        • Anterior Chest Compression technique
        • Abdominal Thrust Technique
        • Rahim yar khan, Punjab, Pakistan
          Sheikh Zayed Hospital, Rahim Yar Khan.
        Jul 7, 2023

        Augmented Reality Usage in Gynecological Laparoscopy on Patients

        Active, not recruiting
        • Myoma;Uterus
        • Adenomyoma of Uterus
        • Gynecological laparoscopic surgery without augmented reality
        • Gynecological laparoscopic surgery with augmented reality
        • Clermont-Ferrand, France
          CHU clermont-ferrand
        Jun 29, 2023

        Host Microbiota and Il-17 in Favoring Multiple Myeloma

        Recruiting
        • Multiple Myeloma
          • Milan, Milano, Italy
            IRCCS Ospedale San Raffaele
          Jan 26, 2023

          Psoriasis Vulgaris, UVB Phototherapy Burn Trial in Qina (Serum Interleukin 17 levels, NB-UVB)

          Completed
          • Psoriasis Vulgaris
          • UVB Phototherapy Burn
          • Serum Interleukin 17 levels
          • NB-UVB
          • Qinā, Qena, Egypt
            South Valley University
          Dec 9, 2022

          Polyp Histology on White Light Colonoscopy

          Completed
          • Colonoscopy
          • +6 more
          • AUTOMATED POLYP CLASSIFICATION
          • Barcelona, Spain
            Hospital Clínic de Barcelona
          Jan 17, 2023

          Episodic Migraine Trial in China, India, Russian Federation (Galcanezumab, Placebo)

          Completed
          Has Results
          • Episodic Migraine
          • Beijing, Beijing, China
          • +39 more
          Jul 27, 2022

          Atopic Dermatitis Trial in Worldwide (Placebo, Upadacitinib, Topical corticosteroids (TCS))

          Active, not recruiting
          Has Results
          • Atopic Dermatitis
          • Placebo
          • +2 more
          • Birmingham, Alabama
          • +189 more
          Mar 8, 2022

          Chronic Non-specific Low Back Pain Trial (exercise therapy)

          Not yet recruiting
          • Chronic Non-specific Low Back Pain
          • exercise therapy
          • (no location specified)
          Apr 15, 2023